HeartSciences Inc. Files 8-K Reporting Financial Statements & Exhibits

What Happened

• HeartSciences Inc. filed a Form 8‑K with the SEC on July 27, 2026 (Accession No. 0001213900-26-081833) reporting Item 9.01—Financial Statements and Exhibits. The filing indicates the company furnished the exhibits listed in the exhibit index in accordance with Item 9.01.

Key Details

• Filing date: July 27, 2026 (Form 8‑K).
• Item reported: 9.01 — Financial Statements and Exhibits.
• Accession number: 0001213900-26-081833.
• The filing presents exhibits; it does not itself announce quarterly earnings, revenue figures, CEO/CFO changes, mergers, or bankruptcy.

Why It Matters

• For investors, an Item 9.01 filing signals that the company has added or updated formal exhibits (such as agreements, supplemental financial statements, or other documents) to its public record. These exhibits can contain material details, so reviewing them is important even when the main 8‑K does not report earnings or management changes.
• Because this filing does not disclose quarterly results, revenue, or executive actions, it does not by itself change reported earnings or guidance — but the attached exhibits may contain relevant contractual or financial disclosures that could affect valuation or future filings. Investors should review the exhibit index and attached documents for specifics.